Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
Open Access
- 27 October 2011
- journal article
- review article
- Published by Hindawi Limited in Experimental Diabetes Research
- Vol. 2012, 1-12
- https://doi.org/10.1155/2012/145754
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of elevated liver function tests results, after the commonly investigated causes have been excluded, and frequently coexists with type 2 diabetes mellitus (T2DM) because the conditions have common risk factors. As both T2DM and NAFLD are related to adverse outcomes of the other, diagnosis and valuation of fatty liver is an important part of the management of diabetes. Although noninvasive methods, such as biomarkers, panel markers, and imaging, may support a diagnostic evaluation of NAFLD patients, accurate histopathological findings cannot be achieved without a liver biopsy. As it is important to know whether steatohepatitis and liver fibrosis are present for the management of NAFLD, liver biopsy remains the gold standard for NAFLD diagnosis and evaluation. Therefore, new investigations of the pathogenesis of NAFLD are necessary to develop useful biomarkers that could provide a reliable noninvasive alternative to liver biopsy.Keywords
This publication has 145 references indexed in Scilit:
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meaningsHepatology, 2010
- Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseHepatology, 2010
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation studyHepatology, 2009
- Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery PatientsClinical Gastroenterology and Hepatology, 2008
- The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicityHepatology, 2007
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersHepatology, 2007
- FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestHepatology, 2007
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDHepatology, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying diseaseHepatology, 1999